Insulet Corporation (NASDAQ: PODD) closed the day trading at $163.60 down -1.81% from the previous closing price of $166.62. In other words, the price has decreased by -$3.02 from its previous closing price. On the day, 1261546 shares were traded. PODD stock price reached its highest trading level at $167.04 during the session, while it also had its lowest trading level at $162.04.
Ratios:
For a better understanding of PODD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 163.90. For the most recent quarter (mrq), Quick Ratio is recorded 2.58 and its Current Ratio is at 3.47. In the meantime, Its Debt-to-Equity ratio is 1.98 whereas as Long-Term Debt/Eq ratio is at 1.91.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on December 21, 2023, Upgraded its rating to Outperform and sets its target price to $238 from $180 previously.
On December 04, 2023, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $185 to $234.
Jefferies Upgraded its Hold to Buy on October 02, 2023, whereas the target price for the stock was revised from $260 to $240.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 15 when BORIO LUCIANA sold 72 shares for $207.08 per share. The transaction valued at 14,910 led to the insider holds 2,278 shares of the business.
Petrovic Shacey sold 20,000 shares of PODD for $3,286,600 on Nov 13. The Director now owns 2,567 shares after completing the transaction at $164.33 per share. On Nov 13, another insider, Petrovic Shacey, who serves as the Director of the company, sold 15,000 shares for $165.02 each. As a result, the insider received 2,475,300 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PODD now has a Market Capitalization of 11.44B and an Enterprise Value of 12.15B. As of this moment, Insulet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 56.18, and their Forward P/E ratio for the next fiscal year is 43.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.74 while its Price-to-Book (P/B) ratio in mrq is 15.61. Its current Enterprise Value per Revenue stands at 7.16 whereas that against EBITDA is 37.55.
Stock Price History:
The Beta on a monthly basis for PODD is 0.99, which has changed by -41.11% over the last 52 weeks, in comparison to a change of 27.55% over the same period for the S&P500. Over the past 52 weeks, PODD has reached a high of $335.91, while it has fallen to a 52-week low of $125.82. The 50-Day Moving Average of the stock is 200.05, while the 200-Day Moving Average is calculated to be 213.83.
Shares Statistics:
Over the past 3-months, PODD traded about 897.57K shares per day on average, while over the past 10 days, PODD traded about 1.21M shares per day. A total of 69.91M shares are outstanding, with a floating share count of 69.40M. Insiders hold about 0.74% of the company’s shares, while institutions hold 102.10% stake in the company. Shares short for PODD as of Feb 15, 2024 were 2.71M with a Short Ratio of 3.02, compared to 2.7M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.88% and a Short% of Float of 4.58%.
Earnings Estimates
Current recommendations for the stock of the company come from 16 analysts. On average, analysts expect EPS of $0.39 for the current quarter, with a high estimate of $0.61 and a low estimate of $0.29, while EPS last year was $0.23. The consensus estimate for the next quarter is $0.56, with high estimates of $0.74 and low estimates of $0.43.
Analysts are recommending an EPS of between $3.3 and $2.44 for the fiscal current year, implying an average EPS of $2.96. EPS for the following year is $3.78, with 18 analysts recommending between $4.35 and $3.2.
Revenue Estimates
17 analysts predict $424.7M in revenue for the current quarter. It ranges from a high estimate of $435.03M to a low estimate of $419.8M. As of the current estimate, Insulet Corporation’s year-ago sales were $358.1M, an estimated increase of 18.60% from the year-ago figure. For the next quarter, 17 analysts are estimating revenue of $458.09M, an increase of 19.00% over than the figure of $18.60% in the same quarter last year. There is a high estimate of $481.7M for the next quarter, whereas the lowest estimate is $442M.
A total of 22 analysts have provided revenue estimates for PODD’s current fiscal year. The highest revenue estimate was $1.99B, while the lowest revenue estimate was $1.94B, resulting in an average revenue estimate of $1.96B. In the same quarter a year ago, actual revenue was $1.7B, up 15.70% from the average estimate. Based on 21 analysts’ estimates, the company’s revenue will be $2.33B in the next fiscal year. The high estimate is $2.44B and the low estimate is $2.28B. The average revenue growth estimate for next year is up 18.70% from the average revenue estimate for this year.
